2021/04/30 ALA-1000 was granted by Intellectual Property Office of New Zealand.Patent No. 750367.Post author:alarpharmPost published:3 . 5 . 2021Post category:Media releases You Might Also Like 2023/09/27 ALA-1300 has received a notice of allowance from The National Office of Intellectual Property of Vietnam (NOIP) after the examination. (Patent Application No. 1-2020-06145) 22 . 2 . 2024 2023/08/02 ALA-3000 has received an Intention to Grant (IGRA) from European Patent Office (EPO) after examination. (Patent Application No. 20739053.5) 10 . 8 . 2023 2020/07/22 ALA -1000 Receive notice of patent allowance from the Mexican Institute of Industrial Property (IMPI) 13 . 8 . 2020 2024/02/22 ALA-3000 has received a notice of allowance from United States Patent and Trademark Office (USPTO) after examination. (Patent Application No. 17/421,407) 29 . 2 . 2024 2023/06/29 ALA-1000 Received the patent, SUSTAINED-RELEASE BUPRENORPHINE FORMULATIONS, from Intellectual Property Corporation of Malaysia (MyIPO) , NO : MY-196269-A 30 . 6 . 2023
2023/09/27 ALA-1300 has received a notice of allowance from The National Office of Intellectual Property of Vietnam (NOIP) after the examination. (Patent Application No. 1-2020-06145) 22 . 2 . 2024
2023/08/02 ALA-3000 has received an Intention to Grant (IGRA) from European Patent Office (EPO) after examination. (Patent Application No. 20739053.5) 10 . 8 . 2023
2020/07/22 ALA -1000 Receive notice of patent allowance from the Mexican Institute of Industrial Property (IMPI) 13 . 8 . 2020
2024/02/22 ALA-3000 has received a notice of allowance from United States Patent and Trademark Office (USPTO) after examination. (Patent Application No. 17/421,407) 29 . 2 . 2024
2023/06/29 ALA-1000 Received the patent, SUSTAINED-RELEASE BUPRENORPHINE FORMULATIONS, from Intellectual Property Corporation of Malaysia (MyIPO) , NO : MY-196269-A 30 . 6 . 2023